Filing Flows › Avita Medical (RCEL) › Guidance history
Avita Medical (RCEL) guidance history: what it guided and what it reported
Avita Medical gave guidance in 3 earnings releases on file since May 14, 2026. Its releases raised guidance twice and lowered it 0 times.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $80.0M–$85.0M (May 14, 2026) → raised $86.0M–$89.0M (Aug 6, 2026) → raised $92.0M–$94.0M (Nov 5, 2026) | — | to be reported | — |
Gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 88.4% (Nov 5, 2026) | — | to be reported | — |
The latest quarter
Avita Medical, Q3 2026: revenue $26.1M (+53% year over year), operating margin -10.1%, net loss $6.2M, operating cash flow −$710K. The chart follows the revenue to costs, profit and cash.
Questions
Does Avita Medical beat its guidance?
Avita Medical gave guidance in 3 earnings releases on file since May 14, 2026. Its releases raised guidance twice and lowered it 0 times.
How often does Avita Medical raise guidance?
Its earnings releases raised guidance twice and lowered it 0 times since May 14, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.